Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer

Oncologist

Volumn 15, Issue 4, 2010, Pages 405-415

  Touboul, Cyril ^a   Uzan, Catherine ^a   Mauguen, Audrey ^a   Gouy, Sebastien ^a   Rey, Annie ^a   Pautier, Patricia ^a   Lhommé, Catherine ^a   Duvillard, Pierre ^a   Haie Meder, Christine ^a   Morice, Philippe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chemoradiation therapy; Completion surgery; Locally advanced cervical cancer; Morbidities; Nodal involvement; Prognostic factors; Residual disease; Survival

Indexed keywords

CISPLATIN;

ABSCESS; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER FISTULA; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHYLOUS ASCITES; CYSTIC LYMPHANGIOMA; EPIGASTRIC PAIN; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HYSTERECTOMY; INTESTINE FISTULA; INTESTINE OBSTRUCTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PERITONITIS; PHLEBITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT RESPONSE; URETER FISTULA; URETER OBSTRUCTION; URINE INCONTINENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; WOUND DEHISCENCE;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; FRANCE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; ODDS RATIO; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77951746040     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0295     Document Type: Article

References (43)

1. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001;358:781-786.
2. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.
3. Houvenaeghel G, Lelievre L, Gonzague-Casabianca L et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 2006;100:338-343.
4. Ferrandina G, Legge F, Fagotti A et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures. Gynecol Oncol 2007;107(suppl 1):S127-S132.
5. Classe JM, Rauch P, Rodier JF et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centres de Lutte Contre le Cancer). Gynecol Oncol 2006;102:523-529.
6. Azria E, Morice P, Haie-Meder C et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol 2005;12:332-337.
7. Darus CJ, Callahan MB, Nguyen QN et al. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma. Int J Gynecol Cancer 2008;18:730-735.
8. Colombo PE, Bertrand MM, Gutowski M et al. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: Surgical morbidity and oncological results. Gynecol Oncol 2009;114:404-409.
9. Huguet F, Cojocariu OM, Levy P et al. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Int J Radiat Oncol Biol Phys 2008;72:1508-1515.
10. Ota T, Takeshima N, Tabata T et al. Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy. Br J Cancer 2008;99:1216-1220.
11. International Federation of Gynecology and Obstetrics. Modifications in the staging for stage I vulvar and stage I cervical cancer. Report of the FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 1995;50:215-216.
12. International Commission on Radiation Units (ICRU). Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology. Report No. 38. Bethesda, MD: ICRU, 1985.
13. Pôtter R, Haie-Meder C, Van Limbergen E et al. GEC ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67-77.
14. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272.
15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
16. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-346.
17. Morice P, Uzan C, Zafrani Y et al. The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer. Gynecol Oncol 2007;107(suppl 1):S122-S124.
18. Pötter R, Dimopoulos J, Georg P et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148-155.
19. Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol 2008;9:297-303.
20. Houvenaeghel G, Lelievre L, Buttarelli M et al. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol 2007;33:498-503.
21. Chargari C, Magné N, Dumas I et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009;74:133-139.
22. Delpech Y, Haie-Meder C, Rey A et al. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol 2007;14:3223-3231.
23. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001;19:3745-3749.
24. Wright JD, Dehdashti F, Herzog TJ et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 2005;104:2484-2491.
25. Boughanim M, Leboulleux S, Rey A et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F] fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 2008;26:2558-2561.
26. Mortier DG, Stroobants S, Amant F et al. Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. Int J Gynecol Cancer 2008;18:723-729.
27. Leblanc E, Narducci F, Frumovitz M et al. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging in locally advanced cervical carcinoma. Gynecol Oncol 2007;105:304-311.
28. Varia MA, Bundy BN, Deppe G et al. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998;42:1015-1023.
29. Lai CH, Huang KG, Hong JH et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 2003;89:160-167.
30. Gold MA, Tian C, Whitney CW et al. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: A Gynecologic Oncology Group Study. Cancer 2008;112:1954-1963.
31. Michel G, Morice P, Castaigne D et al. Lymphatic spread in stage Ib and II cervical carcinoma: Anatomy and surgical implications. Obstet Gynecol 1998;91:360-363.
32. Houvenaeghel G, Lelievre L, Rigouard AL et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 2006;102:74-79.
33. Ferrandina G, Distefano M, Ludovisi M et al. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy. Ann Surg Oncol 2007;14:1129-1135.
34. Kupets R, Thomas GM, Covens A. Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol 2002;87:163-170.
35. Grigsby PW, Singh AK, Siegel BA et al. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 2004;59:706-712.
36. Macdonald DM, Lin LL, Biehl K et al. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:618-624.
37. Eifel PJ, Levenback C, Wharton JT et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995;32:1289-1300.
38. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-540.
39. Perez CA, Breaux S, Bedwinek JM et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 1984;54:235-246.
40. Morice P, Le Bouedec G, Pomel C et al. Complications of primary external radiation therapy followed by radical hysterectomy for bulky stage IB and II cervical cancer. Eur J Cancer 2001;37(suppl 6):1232.
41. Vincens E, Balleyguier C, Rey A et al. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: Correlation of radiologic findings with surgicopathologic results. Cancer 2008;113:2158-2165.
42. Schwarz JK, Siegel BA, Dehdashti F et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 2007;298:2289-2295.
43. McVeigh PZ, Syed AM, Milosevic M et al. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008;18:1058-1064.